Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a ...

The apparatus was an early flight simulator. It was made of wood, like the aircraft it mimicked, and also cannibalized ...

Q3 2024 Earnings Call Transcript November 6, 2024 Guardant Health, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.74. Operator: Hello, everyone, and welcome to the ...

Over a series of conferences during the third quarter 2024, Ocugen had the opportunity to provide an update on its three clinical-stage modifier gene therapies to significant investor audiences as ...

Good morning, and welcome to Y-mAbs Therapeutics Inc. Third Quarter Conference Call for 2024. At this time, all participants are in a listen-only mode. Instruction for the question-and-answer session ...

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA,” the “Company,” or “we”), an end-to-end commercial biopharmaceutical company ...

Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.